NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH)
Post# of 12
(Total Views: 280)
Posted On: 02/10/2022 3:25:21 PM
NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System
RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company’s IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was recently granted Medical Device Certification under ISO 13485:2016/MDSAP and EN ISO 13485:2016 standards for both its hardware and software. “Receiving this Notice of Allowance by the USPTO on our Smart Medical Inhaler is the result of dedication and great effort by all of our product team members, with particular thanks to our Product Operations Head, Jordan Medley, and our patent legal team. The application for this invention was initially filed on March 16, 2018, and was subject to several amendments along the way,” said Gregory Wagner, CEO of RYAH Group Inc. “We look forward to strengthening competitive positioning on our intellectual property and medical device portfolio with a number of patents pending maturing on our additional IoT products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company’s IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was recently granted Medical Device Certification under ISO 13485:2016/MDSAP and EN ISO 13485:2016 standards for both its hardware and software. “Receiving this Notice of Allowance by the USPTO on our Smart Medical Inhaler is the result of dedication and great effort by all of our product team members, with particular thanks to our Product Operations Head, Jordan Medley, and our patent legal team. The application for this invention was initially filed on March 16, 2018, and was subject to several amendments along the way,” said Gregory Wagner, CEO of RYAH Group Inc. “We look forward to strengthening competitive positioning on our intellectual property and medical device portfolio with a number of patents pending maturing on our additional IoT products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)